DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Medical School
  3. HMS Theses and Dissertations
  4. Characterizing the role of ETV6 in lymphoid development and B-cell acute lymphoblastic leukemia predisposition

Characterizing the role of ETV6 in lymphoid development and B-cell acute lymphoblastic leukemia predisposition

Open/View files
JP_MMScThesis_FINAL.pdf (2.39 MB)
Date
May 10, 2023
Author(s)
Pak, Jensen Joonho
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Pak, Jensen Joonho. 2022. Characterizing the role of ETV6 in lymphoid development and B-cell acute lymphoblastic leukemia predisposition. Master's thesis, Harvard Medical School.
Abstract
B cell acute lymphoblastic leukemia (ALL) is the most common form of pediatric cancer and one of the leading causes of death in children, characterized by clonal expansion of malignant lymphoid progenitors. While recent studies have identified a number of genetic risk factors for the development of ALL, our understanding of the mechanism of susceptibility to the disease remains incomplete. Sequencing studies have implicated germline ETV6 mutations to predispose patients to development of blood cancers and particularly to B-cell ALL. However, the specific role for ETV6 has not been characterized. Here, I investigated the role of germline ETV6 mutations in human B cell lymphopoiesis and predisposition to ALL. Human cord blood-derived and adult peripherally mobilized CD34+ cells were edited using a CRISPR-Cas9 editing strategy that has been established in our laboratory. I established an optimized in vitro co-culture system for B cell differentiation from hematopoietic stem cells. I examined the effects of this knockdown on cellular differentiation, including flow cytometry for phenotypic analysis of different stages of B cell lymphopoiesis. Perturbation of ETV6, particularly in the ETS domain, in CD34+ HSPCs produced an altered lymphoid progenitor pool, notably a reduction in CD45RA+CD33-- and a subtle increase in CD19+-expressing cells at one week of differentiation. Understanding the role of germline ETV6 variation offers unique insight into the molecular etiology of and predisposition to ALL, providing future opportunities for treatment and potential prevention.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37375087
Subjects

B-ALL

ETV6

hematopoiesis

leukemia predispositi...

lymphoid development

MMSc Immunology

Immunology

Collection
HMS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.